Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Nomogram for Predicting Prognostic Assessment of Traumatic Intracranial Hematoma: A Retrospective Cohort Study.

World neurosurgery·2025
Same author

Dysfunction of a lepidopteran conserved gene, BmBLOC1S6, causes a translucent larval integument in the silkworm, Bombyx mori.

Pest management science·2025
Same author

Targeting FOXM1 condensates reduces breast tumour growth and metastasis.

Nature·2025
Same author

Gut microbiota protect against colorectal tumorigenesis through lncRNA Snhg9.

Developmental cell·2025
Same author

Umbilical cord mesenchymal stem cell-derived exosomal Follistatin inhibits fibrosis and promotes muscle regeneration in mice by influencing Smad2 and AKT signaling.

Experimental cell research·2024
Same author

Dabrafenib upregulates hypoglycosylated MUC1 and improves the therapeutic efficacy of Tn-MUC1 CAR-T cells.

Science bulletin·2024

Related Experiment Video

Updated: May 31, 2025

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

8.1K

Extracellular vesicular microRNAs and cardiac hypertrophy.

Hai Hu1,2, Xiulian Wang1, Hui Yu1,2

  • 1Inner Mongolia Key Laboratory of Disease-Related Biomarkers, The Second Affiliated Hospital, Baotou Medical College, Baotou, China.

Frontiers in Endocrinology
|January 24, 2025
PubMed
Summary

Extracellular vesicle-derived microRNAs (miRNAs) are key players in cardiac hypertrophy, a condition leading to heart failure. Understanding these miRNAs offers potential diagnostic and therapeutic strategies for heart disease.

Keywords:
cardiac hypertrophyextracellular vesicleinflammationmicroRNAregulatory mechanism

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.3K
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.0K

Related Experiment Videos

Last Updated: May 31, 2025

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

8.1K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.3K
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.0K

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Extracellular Vesicle Research

Background:

  • Cardiac hypertrophy is a response to heart overload, often leading to heart failure.
  • Its progression involves complex cellular and molecular changes.
  • Identifying inhibitory molecular mechanisms is crucial for new therapies.

Purpose of the Study:

  • To review recent advancements in extracellular vesicle (EV) research.
  • To highlight the role of EV-derived microRNAs (miRNAs) in cardiac hypertrophy.
  • To discuss the diagnostic and therapeutic potential of EV-derived miRNAs.

Main Methods:

  • Review of current literature on extracellular vesicles and cardiac hypertrophy.
  • Analysis of EV biogenesis, cargoes, and miRNA functions.
  • Examination of regulatory mechanisms of EV-derived miRNAs.

Main Results:

  • EVs and their miRNA cargo are significantly involved in cardiac hypertrophy development.
  • EV-derived miRNAs exhibit specific functions and regulatory roles in this condition.
  • Recent findings illuminate the complex interplay between EVs, miRNAs, and cardiac remodeling.

Conclusions:

  • EV-derived miRNAs are critical mediators in cardiac hypertrophy.
  • These miRNAs hold promise as biomarkers for diagnosis.
  • Targeting EV-derived miRNAs presents a novel therapeutic avenue for heart failure.